NCT01266109

Brief Summary

Juvenile drug courts were developed in response to a perceived need to intervene more effectively with youth with substance abuse problems. Close collaboration between the court and substance abuse treatment provider is a defining component of the drug court model and is critical to helping youth achieve positive outcomes. Despite the proliferation of juvenile drug courts in recent years, however, evaluation of their capacity to reduce offender substance use and criminal activity has lagged. Moreover, the Institute of Medicine (IOM, 1998) and leading experts (McLellan, Carise, \& Kleber, 2003) have presented a bleak picture of the nation's capacity to meet the treatment needs of substance abusing individuals. Although community-based programs provide the backbone of substance abuse treatment in the nation, their capabilities have not kept up with major scientific advances in the development and validation of evidence-based substance abuse interventions. Building on our research findings and experience regarding juvenile drug court outcomes as well as the transport of evidence-based practices to community treatment settings, the purpose of this study is to develop and test a relatively flexible and low cost strategy for enhancing the outcomes of juvenile drug courts by integrating components of evidence-based treatments into existing substance abuse services. Specifically, this project aims to: Aim 1: Adapt existing intervention and training protocols from evidence-based practices (i.e., Contingency Management for adolescent substance abuse; family engagement strategies from evidence-based treatments of juvenile offenders) for integration into juvenile drug court sites. Aim 2: Conduct a study to examine youth (e.g., substance use and criminal behavior) and system level (e.g., intervention adherence, feasibility, retention and completion rates, consumer satisfaction, cost estimates) effects of implementing the intervention protocols in juvenile drug courts. Aim 3: Revise the intervention and training protocols in preparation for a Stage II study if findings are supportive.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Sep 2007

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 24, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
Last Updated

June 18, 2013

Status Verified

May 1, 2013

Enrollment Period

4.5 years

First QC Date

November 18, 2010

Last Update Submit

June 17, 2013

Conditions

Adolescent Substance Use

Keywords

Substance UseDelinquencyJuvenile Drug CourtContingency ManagementFamily Engagement

Outcome Measures

Primary Outcomes (1)

  • Substance Use

    Quarterly for up to 1 year post-baseline

Secondary Outcomes (4)

  • Delinquency

    Quarterly for up to 1 year post-baseline

  • Intervention Fidelity

    Monthly for up to 1 year post-baseline

  • Cost Estimates

    Annually for 4 years

  • Consumer Satisfaction

    Bi-annually for 4 years

Study Arms (2)

CM-FAM

EXPERIMENTAL
Behavioral: Contingency Management-Family Engagement (CM-FAM)

US

ACTIVE COMPARATOR
Other: Usual Services (US)

Interventions

Contingency Management-Family Engagement (CM-FAM)BEHAVIORAL

Evidence-based outpatient intervention for adolescent substance use

CM-FAM
Usual Services (US)OTHER

Typical community-based substance abuse treatment services

US

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Juvenile Drug Court-involved youth
  • Fluency in English

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Related Publications (3)

  • Tuerk EH, McCart MR, Henggeler SW. Collaboration in family therapy. J Clin Psychol. 2012 Feb;68(2):168-78. doi: 10.1002/jclp.21833.

    PMID: 23616297BACKGROUND

  • Henggeler SW, McCart MR, Cunningham PB, Chapman JE. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices. J Consult Clin Psychol. 2012 Apr;80(2):264-75. doi: 10.1037/a0027147. Epub 2012 Feb 6.

    PMID: 22309470RESULT

  • McCart MR, Henggeler SW, Chapman JE, Cunningham PB. System-level effects of integrating a promising treatment into juvenile drug courts. J Subst Abuse Treat. 2012 Sep;43(2):231-43. doi: 10.1016/j.jsat.2011.10.030. Epub 2011 Dec 5.

    PMID: 22154039RESULT

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Scott W Henggeler, Ph.D.

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2010

First Posted

December 24, 2010

Study Start

September 1, 2007

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

June 18, 2013

Record last verified: 2013-05

Locations

US(1)